Obesity and prostate cancer

Current Opinion in Urology

Volumn 15, Issue 1, 2005, Pages 13-16

  Presti Jr , Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Obesity; Prostate cancer

Indexed keywords

INTERLEUKIN 6; LEPTIN; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C;

DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HEALTH PRACTITIONER; HUMAN; NEEDLE BIOPSY; OBESITY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; OBESITY; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 12144268372     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200501000-00004     Document Type: Review

References (21)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-1727.
2. Bray GA. The underlying basis for obesity: relationship to cancer. J Nutr 2002; 132:3451S-3455S.
3. Andersson SO, Wolk A, Bergstrom R, et al. Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 1997; 89:385-389.
4. Giovannuucci E, Rimm EB, Stampfer MJ, et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:557-563.
5. Giovannuucci E, Rimm EB, Liu Y, et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 2003; 95:1240-1244. Obesity was associated with a decreased risk for prostate cancer in men under the age of 60 or in men with a positive family history of prostate cancer.
6. Schuurman AG, Goldbohm RA, Dorant E, Van den Brandt PA. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000; 151:541-549.
7. Aziz NM, Hartman T, Barrett B. Weight and prostate cancer in the Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Trial. J Clin Oncol 2000; 19:647a [abstract no. 2550].
8. Jonsson F, Wolk A, Pedersen NL, et al. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry. Int J Cancer 2003; 106:594-599.
9. Hubbard JS, Rohrmann S, Landis PK, et al. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore Longitudinal Study of Aging. Urology 2004; 63:253-258.
10. Laaksonen DE, Laukkanen JA, Niskanen L, et al. Serum linoleic acid and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study. Int J Cancer 2004; 111:444-450. Increased dietary linoleic and polyunsaturated fats decreased the risk of prostate cancer independent of obesity and physical activity.
11. Thompson IM, Leach R, Troyer D, et al. Relationship of body mass index and prostate specific antigen in a population-based study. Urol Oncol 2004; 22:127-131.
12. Presti JC Jr, Lee U, Brooks JD, Terris MK. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathologic features in a biopsy population. J Urol 2004; 171:2199-2202. In a referral-based biopsy population, BMI was inversely related to detection rate in men under the age of 70.
13. Amling CL, Riffenburgh RH, Sun L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22:439-445. Largest radical prostatectomy series demonstrating that obesity is associated with worse pathological features and a higher biochemical failure rate.
14. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study group. J Clin Oncol 2004; 22:446-453.
15. Freedland SJ, Terris MK, Presti JC Jr, et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 2004; 172:520-524. Radical prostatectomy series demonstrating that obesity is associated with a higher biochemical failure rate even in men with negative surgical margins.
16. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectiveiy studied cohort of U.S. adults. N Engl J Med 2003; 348:1625-1638.
17. Gapstur SM, Gann PH, Kopp P, et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 2002; 11:1041-1047.
18. Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction. Leptin mediates androgen independent prostate cancer cell proliferation through c-jun NH2-terminal kinase. J Biol Chem 2003; 278:42660-42667. Mechanistic description of how leptin, a product of adipocytes, might enhance the proliferation of androgen-independent prostate cancer.
19. Drachenberg DE, Elgamal AA, Rowbotham R, et al. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999; 41:127-133.
20. Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279:563-566.
21. Chan JM, Stampfer MJ, Ma J, et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002; 94:1099-1106.